-transparent.png){kind=logo}
The effect of the calcium channel blockers nifedipine (9 and 18 micrograms kg-1 h-1), diltiazem (100 and 200 micrograms kg-1 h-1) and verapamil (19 micrograms kg-1 h-1) continuously infused during haemodialysis on granulocyte and complement activation was investigated. Plasma levels of lactoferrin, elastase in complex with alpha 1-proteinase inhibitor (E-alpha 1PI) and C3a were measured in patients dialysed with dialysers made of cuprophane, polymethylmethacrylate (PMMA) and polyacrylonitrile (PAN). Calcium channel blockers caused no change of blood pressure during haemodialysis in all patients. There was no effect of nifedipine, diltiazem or verapamil on plasma lactoferrin, E-alpha 1PI or C3a levels in patients dialysed with cuprophane. However, plasma lactoferrin and E-alpha 1PI values were significantly reduced by all calcium channel blockers in patients dialysed with PMMA, and also by nifedipine and verapamil in patients dialysed with PAN. Our data indicate that calcium channel blockers inhibit granulocyte activation occurring in dialysers with very little anaphylatoxin formation. These drugs, however, are ineffective in patients dialysed with cuprophane where complement activation takes place. Therefore, granulocyte activation during haemodialysis in the absence of complement activation seems to be mediated by calcium ions.
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
January 1985,
International journal of immunopharmacology,
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
January 1993,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
October 1985,
Cellular immunology,
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
November 2002,
Clinical science (London, England : 1979),
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
December 1985,
Scandinavian journal of clinical and laboratory investigation,
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
February 1990,
Hypertension (Dallas, Tex. : 1979),
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
September 1985,
The American review of respiratory disease,
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
September 2012,
Neuropharmacology,
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
February 2010,
Heart (British Cardiac Society),
M Haag-Weber, and
P Schollmeyer, and
W H Hörl
May 2016,
Artificial organs,
